Magdalena Klink

Years Active: 2019-2022
Publications (10 Years): 6

Institute of Medical Biology Polish Academy of Sciences

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute of Medical Biology Polish Academy of Sciences Jan 01 2004

Poland

Professor

Publications

Michal Kielbik, Izabela Szulc-Kiełbik, Magdalena Klink
E-Cadherin Expression in Relation to Clinicopathological Parameters and Survival of Patients with Epithelial Ovarian Cancer. International journal of molecular sciences 23 (22) (2022)
Michal Kielbik, Izabela Szulc-Kiełbik, Magdalena Klink
Calreticulin-Multifunctional Chaperone in Immunogenic Cell Death: Potential Significance as a Prognostic Biomarker in Ovarian Cancer Patients. Cells 10 (1) (2021)
Michal Kielbik, Izabela Szulc-Kiełbik, Magdalena Klink
Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level. International journal of molecular sciences 22 (2) (2021)
Marek Nowak, Magdalena Klink
The Role of Tumor-Associated Macrophages in the Progression and Chemoresistance of Ovarian Cancer. Cells 9 (5) (2020)
Milosz Wilczynski, Michal Kielbik, Daria Senderowska, Tomasz Krawczyk, Bozena Szymanska, Magdalena Klink, Jan Bieńkiewicz, Hanna Romanowicz, Filip Frühauf, Andrzej Malinowski
MiRNA-103/107 in Primary High-Grade Serous Ovarian Cancer and Its Clinical Significance. Cancers 12 (9) (2020)
Izabela Szulc-Kiełbik, Michal Kielbik, Patrycja Przygodzka, Anna Brzostek, Jarosław Dziadek, Magdalena Klink
Mycobacterium tuberculosis Requires Cholesterol Oxidase to Disrupt TLR2 Signalling in Human Macrophages. Mediators of inflammation 2019 (2019)

Magdalena Klink.css-eqlu8i{font-size:small;padding-left:4px;}